Jr. Allport et al., A POSSIBLE ROLE FOR MONO(ADP-RIBOSYL)TRANSFERASE IN THE SIGNALING PATHWAY MEDIATING NEUTROPHIL CHEMOTAXIS, British journal of clinical pharmacology, 42(1), 1996, pp. 99-106
1 Mono(ADP-ribosyl) transferase activity has been identified on the ex
ternal surface of human polymorphonuclear neutrophil leucocytes (PMNs)
. The enzyme is released from the plasma membrane by phosphoinositide-
specific phospholipase C, suggesting a glycosylphosphatidylinositol (G
PI) linkage of the enzyme to the plasma membrane. Partial sequence of
cDNA encoding the enzyme suggests that it is identical to the GPI-link
ed mono(ADP-ribosyl)transferase identified previously on human skeleta
l muscle. 2 A panel of inhibitors of mono (ADP-ribosyl)transferase (in
cluding vitamins K-1 and K-3, novobiocin and nicotinamide) showed a ra
nk order of inhibitory potency similar to that described for other mon
o(ADP-ribosyl) transferases. Furthermore, the mono(ADP-ribosyl)ation o
f agmatine was inhibited also by diethylamino (benzylidineamino) guani
dine (DEA-BAG), another substrate of the enzyme related structurally t
o arginine. 3 There was a close linear correlation between the IC50 va
lues for inhibition of mono(ADP-ribosyl) ation of agmatine by DEA-BAG
or the enzyme inhibitors and their IC50 values for inhibition of recep
tor-dependent polymerization of cytoskeletal actin and chemotaxis. 4 T
hese results suggest a role for mono(ADP-ribosyl) transferase in the t
ransduction pathway involved in receptor-dependent re-alignment of the
cytoskeleton during neutrophil chemotaxis.